Interpretation of Guidelines for the Investigation of Chronic Diarrhoea in Adults: British Society of Gastroenterology in 2018

doi:10.12114/j.issn.1007-9572.2020.00.432

Abstract

Abstract: The 3rd edition of the Guidelines for the Investigation of Chronic Diarrhoea in Adults was published online in Gut by the British Society of Gastroenterology in April 2018，which updated the 2nd edition of the guidelines in 2003. This new edition of the guidelines describes the clinical assessment process，tumor and inflammation assessment，malabsorption test，and the management of common causes，structural/surgical causes and rare causes in chronic diarrhoea. Based on the updated contents of this guideline，this paper discusses the common misunderstandings in the diagnosis and treatment of adult chronic diarrhoea，including incomplete collection of medical history and difficulty in etiological diagnosis；failure to consider bile acid diarrhoea as a common cause of chronic diarrhoea；delayed diagnosis and treatment of celiac disease；failure to take biopsy in colonoscopy；missed diagnosis of colorectal cancer in young patients with chronic diarrhoea；non identification of overflow diarrhoea in the elderly；lack of awareness of the clinical significance of intestinal bacterial overgrowth detection method，and the corresponding countermeasures are proposed.

Key words: Diarrhoea, Adults, Guideline, Interpretation

摘要： 2018年4月英国胃肠病学会（BSG）在Gut上发表了第3版《成人慢性腹泻的调查指南》，对2003年第2版指南进行了更新，新版指南对慢性腹泻的临床评估流程、肿瘤和炎症评估、吸收不良的检测，以及常见病因、结构性/手术病因、少见病因的管理等方面进行阐述。本文结合此指南更新内容探讨成人慢性腹泻诊疗中的常见误区，包括：病史采集不全面，病因诊断困难；未把胆汁酸性腹泻作为慢性腹泻的常见病因考虑；乳糜泻诊治延迟；结肠镜检查不取活检；年轻慢性腹泻患者中漏诊结直肠癌；对老年人溢出性腹泻不识别；对小肠细菌过度生长检测方法的临床意义认知不足，针对这些误区给出相应的应对策略。

关键词: 腹泻, 成年人, 指南, 解读

ZHU Xinying,ZHAO Dongqiang. Interpretation of Guidelines for the Investigation of Chronic Diarrhoea in Adults: British Society of Gastroenterology in 2018　[J]. Chinese General Practice, 2021, 24(7): 780-783. DOI: 10.12114/j.issn.1007-9572.2020.00.432.
朱新影,赵东强. 2018年英国胃肠病学会《成人慢性腹泻的调查指南》解读[J]. 中国全科医学, 2021, 24(7): 780-783. DOI: 10.12114/j.issn.1007-9572.2020.00.432.

References

［1］FAGUNDES-NETO U．Persistent diarrhea：still a serious public health problem in developing countries［J］．Curr Gastroenterol Rep，2013，15（9）：345．DOI：10.1007/s11894-013-0345-1.
［2］ARASARADNAM R P，BROWN S，FORBES A，et al．Guidelines for the investigation of chronic diarrhoea in adults：British Society of Gastroenterology，3rd edition［J］．Gut，2018，67（8）：1380-1399．DOI：10.1136/gutjnl-2017-315909.
［3］张莉娟，江勇，刘炳华，等．成年人慢性腹泻病因的研究进展［J］．中国全科医学，2019，22（22）：2760-2765．DOI：10.12114/j.issn.1007-9572.2019.00.378.
ZHANG L J，JIANG Y，LIU B H，et al．Advances in the etiology of chronic diarrhea in adults ［J］．Chinese General Practice，2019，22（22）：2760-2765．DOI：10.12114/j.issn.1007-9572.2019.00.378.
［4］VALENTIN N，CAMILLERI M，ALTAYAR O，et al．Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea：a systematic review and meta-analysis ［J］．Gut，2016，65（12）：1951-1959．DOI：10.1136/gutjnl-2015-309889.
［5］WEDLAKE L，A'HERN R，RUSSELL D，et al．Systematic review：the prevalence of idiopathic bile acid malabsorption（I-BAM） as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome（IBS）［J］．Aliment Pharmacol Ther，2009，30（7）：707-717．
［6］BANNAGA A，KELMAN L，O'CONNOR M，et al．How bad is bile acid diarrhoea：an online survey of patient-reported symptoms and outcomes［J］．BMJ Open Gastroenterol，2017，4（1）：e000116．DOI：10.1136/bmjgast-2016-000116.
［7］TURNER J M，PATTNI S S，APPLEBY R N，et al．A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhea［J］．Frontline Gastroenterol，2017，8（4）：279-283．DOI：10.1136/flgastro-2017-100826.
［8］FERNANDES D C R，POON D，WHITE L L，et al．What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?［J］．Frontline Gastroenterol，2019，10（1）：72-76.DOI：10.1136/flgastro-2018-101011.
［9］ROSS S，D'MELLO M，ANAND S S，et al．Effect of bile acid sequestrants on the risk of cardiovascular events：a mendelian randomization analysis［J］．Circ Cardiovasc Genet，2015，8（4）：618-627．DOI：10.1161/CIRCGENETICS.114.000952.
［10］SAUTER G H，MüNZING W，VON RITTER C，et al．Bile acid malabsorption as a cause of chronic diarrhea：diagnostic value of 7-alpha-hydroxy-4-cholesten-3-one in serum ［J］．Dig Dis Sci，1999，44（1）：14-19．DOI：10.1023/a:1026681512303.
［11］CAMILLERI M．Advances in understanding of bile acid diarrhea［J］．Expert Rev Gastroenterol Hepatol，2014，8（1）：49-61．DOI：10.1586/17474124.2014.851599.
［12］CAMILLERI M，BUSCIGLIO I，ACOSTA A，et al．Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea［J］．Am J Gastroenterol，2014，109（10）：1621-1630．DOI：10.1038/ajg.2014.215.
［13］VIJAYVARGIYA P，CAMILLERI M，CARLSON P，et al．Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhea［J］．Aliment Pharmacol Ther，2017，46（6）：581-588．DOI：10.1111/apt.14214.
［14］VIJAYVARGIYA P，CAMILLERI M，CHEDID V，et al．Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea ［J］．Clin Gastroenterol Hepatol，2019，17（5）：922-929．DOI：10.1016/j.cgh.2018.05.050．
［15］OREKOYA O，MCLAUGHLIN J，LEITAO E，et al．Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy［J］．Clin Med，2015，15（3）：252-257．DOI：10.7861/clinmedicine.15-3-252．
［16］TORTORA R，ZINGONE F，RISPO A，et al．Coeliac disease in the elderly in a tertiary centre［J］．Scand J Gastroenterol，2016，51（10）：1179-1183．DOI：10.1080/00365521.2016.1186222.
［17］FUCHS V，KURPPA K，HUHTALA H，et al．Factors associated with long diagnostic delay in celiac disease［J］．Scand J Gastroenterol，2014，49（11）：1304-1310．DOI：10.3109/00365521.2014.923502.
［18］AL-TOMA A，VOLTA U，AURICCHIO R，et al．European Society for the Study of Coeliac Disease（ESsCD） guideline for coeliac disease and other gluten-related disorders［J］．United European Gastroenterol，2019，7（5）：583-613．
［19］GUAGNOZZI D，ARIAS á，LUCENDO A J．Systematic review with meta-analysis：diagnostic overlap of microscopic colitis and functional bowel disorders［J］．Aliment Pharmacol Ther，2016，43（8）：851-862．DOI：10.1111/apt.13573.
［20］NGUYEN G C，SMALLEY W E，VEGE S S，et al．American Gastroenterological Association Institute guideline on the medical management of microscopic colitis［J］．Gastroenterology，2016，150（1）：242-246．DOI：10.1053/j.gastro.2015.11.008.
［21］PARDI D S，TREMAINE W J，CARRASCO-LABRA A．American Gastroenterological Association Institute technical review on the medical management of microscopic colitis［J］．Gastroenterology，2016，150（1）：247-274．DOI：10.1053/j.gastro.2015.11.006.
［22］LANGNER C，AUST D，ENSARI A，et al．Histology of microscopic colitis-review with a practical approach for pathologists［J］．Histopathology，2015，66（5）：613-626．
［23］PATEL S G，AHNEN D J．Colorectal cancer in the young［J］．Curr Gastroenterol Rep，2018，20（4）：15．DOI：10.1007/s11894-018-0618-9.
［24］RHODES J M，MIDDLETON P，JEWELL D P．The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth［J］．Scand J Gastroenterol，1979，14（3）：333-336．DOI：10.3109/00365527909179892.
［25］CHOUNG R S，RUFF K C，MALHOTRA A，et al．Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture［J］．Aliment Pharmacol Ther，2011，33（9）：1059-1067．DOI：10.1111/j.1365-2036.2011.04625.x.
［26］ERDOGAN A，RAO S S，GULLEY D，et al．Small intestinal bacterial overgrowth：duodenal aspiration vs. glucose breath test［J］．Neurogastroenterol Motil，2015，27（4）：481-489．DOI：10.1111/nmo.12516.

[1]	CHEN Dian, LONG Huanyu, CHU Lanhe, JIANG Yixia, GUO Wanjin, NIU Yang, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2026 Report [J]. Chinese General Practice, 2026, 29(21): 2913-2932.
[2]	CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807.
[3]	LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835.
[4]	CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758.
[5]	HEI Moran, MA Hui'e, XU Zecheng, YAN Shiyan, LI Ziyan, YANG Yi, JIN Jun, CHEN Zelin, GUO Yi, ZHAO Xue, ZHAO Tianyi. Comparison, Analysis and Considerations of Methods for Determining Clinical Questions in Domestic and International Clinical Practice Guideline Development Manuals [J]. Chinese General Practice, 2026, 29(18): 2554-2560.
[6]	FAN Meixiang, YAN Yunyun, HUANG Yanyan. Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer [J]. Chinese General Practice, 2026, 29(18): 2450-2453.
[7]	TONG Min, WANG Ying, XU Yanshen, ZENG Yongjian, WEN Hua, LIU Xue, SUN Xiangjuan, ZHANG Fenghua. Functional Dyspepsia Guideline Quality Assessment: Based on AGREE Ⅱ and RIGHT Tools [J]. Chinese General Practice, 2026, 29(17): 2410-2417.
[8]	WANG Yibo, HE Kaiyu, LIANG Guofen, YANG Zhenhua, ZHAO Tingxian, LIAO Biyi, ZHANG La, LIU Shiwei, GONG Xuezhong, LIU Xusheng, GU Yueyu, QIN Xindong, SU Guobin. Diagnosis and Management of Recurrent Urinary Tract Infections in Women: a Comparison and Interpretation Based on Existing Guidelines and Evidence [J]. Chinese General Practice, 2026, 29(17): 2387-2399.
[9]	MENG Zixi, ZHAO Huiduo, LIU Ruidong, WANG Beibei, JIANG Mingqiang, CHENG Xufeng. Guidelines for Diagnosis and Treatment of Acute Mastitis with Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2026, 29(17): 2273-2281.
[10]	YANG Tingting, ZHENG Li, LIANG Daqiang, WU fan, YUAN Xianxian, WEI lai, HU Jin, WANG Junhua, WANG Ziyun. Association between Sleep Fragmentation and Arteriosclerosis among Population Aged 40-65 Years [J]. Chinese General Practice, 2026, 29(16): 2190-2197.
[11]	Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139.
[12]	GUO Jiao, ZHANG Gaojing, LIU Xincan. Quality Evaluation of TCM Clinical Practice Guidelines/Consensus: Based on Two Guideline Evaluation Tools [J]. Chinese General Practice, 2026, 29(15): 2100-2106.
[13]	Nephrology Branch of China Association of Chinese Medicine, Nephrology Committee of Guangdong Provincial Association of Chinese Medicine, SU Peiling, YANG Lihong, BAO Kun. Diagnosis and Treatment Guideline of Integrated Traditional Chinese and Western Medicine for Idiopathic Membranous Nephropathy (2025) [J]. Chinese General Practice, 2026, 29(15): 1953-1970.
[14]	ZHANG Qiang, ZHAO Wenxia, WANG Ziyi, YAN Le, LIANG Haowei, WANG Jinfan, FANG Jinhua, LU Cuncun. Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024) [J]. Chinese General Practice, 2026, 29(13): 1766-1775.
[15]	WANG Yeming, ZHOU Qi, LI Jingya, CHEN Siying, WANG Junrui, DUAN Qinlei, CHEN Yaolong, CAO Bin, Respiratory Disease Branch of the Chinese Medical Association, Infectious Diseases Branch of Chinese Medical Association. Chinese Guidelines for the Treatment and Prophylaxis of Influenza in Primary Care (2025 Edition) [J]. Chinese General Practice, 2026, 29(13): 1633-1644.